Contents
Special Issue Topic

Drug Adherence in Hypertension

Submission Deadline: April 30, 2025

Guest Editor

Prof. Sverre E. Kjeldsen E-Mail

Professor, Institute of Clinical Medicine, University of Oslo, Oslo, Norway

About the Special lssue

Major fractions of people who have been diagnosed with hypertension remain with uncontrolled high blood pressure. Causes include inertia, a term used to characterize a situation in which physicians do not prescribe or up-titrate antihypertensive medication when there is a clear indication. Alternatively, patients themselves poorly follow advice to take their antihypertensive medications, more drugs or higher doses when recommended. There are several methods in use to investigate drug adherence, some of which are much better than others. Self-reports and questionnaires are in general poor methods to investigate and clarify the degree of poor drug adherence. Pill counts have been used in major outcomes studies but depend on patients not on purpose throwing away pills removed from the package. Electronic systems are in use and may have improved the registration of drug adherence, registering the opening of the pill box caps or the passage of pills through the gastrointestinal system. Direct observed treatment (DOT) in an indirect method can be used under observation. Drug measurements in body fluids, usually urine or blood, are gathering momentum. The usefulness of drug measurements to a certain degree depends on patients being unaware of measurements being done to avoid “white coat adherence”. Drug adherence is a major topic for research, and progress in this field is moving rapidly ahead.

Keywords: Antihypertensive treatment, blood pressure, hypertension, inertia, pharmacotherapy

Published Articles

Open Access Review
Scalable strategies for improving adherence in adults with hypertension—review
The global epidemic of hypertension remains largely uncontrolled and is a leading contributor to noncommunicable disease deaths worldwide. Failure to detect and to adequately treat hypertension is t
Published: March 28, 2025 Explor Med. 2025;6:1001298
368 6 0
Open Access Mini Review
The benefits of a team-based care approach to improve drug adherence in hypertension
Team-based care is a patient management strategy involving a team of at least two healthcare professionals working collaboratively toward a shared clinical goal. This approach is now increasingly re
Published: February 18, 2025 Explor Med. 2025;6:1001285
738 18 0
Open Access Original Article
Characteristics of adherent and non-adherent patients with hypertension in a Norwegian cross-sectional study
Aim: Non-adherence is an important cause of uncontrolled hypertension. We investigated the prevalence of non-adherence to antihypertensive medications by serum drug concentration measurements in
Published: February 07, 2025 Explor Med. 2025;6:1001279
399 14 0
Open Access Review
Medication adherence and non-adherence in arterial hypertension: a narrative review
Systemic hypertension, a significant global health issue and a leading risk factor for cardiovascular mortality affects half of the adult population, with increasing prevalence notably in low- and m
Published: January 23, 2025 Explor Med. 2025;6:1001276
1135 45 0
Open Access Mini Review
Hypertension management and treatment adherence in patients on permanent hemodialysis therapy
Hypertension (HTN) is connected to many complications such as stroke, heart attack, heart failure, and kidney damage. Aging, lifestyle modifications, and obesity are risk factors associated with art
Published: November 19, 2024 Explor Med. 2024;5:870–879
1033 22 0
Open Access Original Article
Analysis of medication adherence of chronic hypertensive patients in Pakistani community via open survey method
Aim: Hypertension, a prevalent chronic condition, significantly contributes to cardiovascular diseases worldwide. Effective management of hypertension is highly dependent on patient adherence to
Published: October 23, 2024 Explor Med. 2024;5:674–683
1740 32 0